STOCK TITAN

[Form 4] FIRST BUSEY CORP /NV/ Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Insider grant of restricted stock units to CFO

Form 4 shows Christopher H.M. Chan, Chief Financial Officer and reporting person at First Busey Corp (BUSE), received a grant of 21,395 restricted stock units on 10/08/2025. The award was reported as an acquisition at a $0 per-share price and is described as vesting on the third anniversary of the grant date, meaning the units become payable around 10/08/2028 if vesting conditions are met. The filing was signed by an attorney-in-fact on 10/10/2025. No derivative transactions or cash purchases are reported.

Assegnazione interna di unità azionarie ristrette al CFO

Il modulo 4 mostra Christopher H.M. Chan, Chief Financial Officer e persona reportante presso First Busey Corp (BUSE), che ha ricevuto un'assegnazione di 21.395 unità azionarie ristrette il 10/08/2025. L'assegnazione è stata riportata come un'acquisizione al prezzo per azione di 0 dollari e viene descritta come maturante al terzo anniversario della data di concessione, il che significa che le unità diventeranno pagabili verso 10/08/2028 se venissero soddisfatte le condizioni di vesting. La pratica è stata firmata da un procuratore ad acta il 10/10/2025. Non sono riportate transazioni derivate né acquisti in contanti.

Concesión interna de unidades de acciones restringidas al CFO

El Formulario 4 muestra Christopher H.M. Chan, Chief Financial Officer y persona reportante de First Busey Corp (BUSE), quien recibió una adjudicación de 21,395 unidades de acciones restringidas el 10/08/2025. La adjudicación se informó como una adquisición a un precio de 0 dólares por acción y se describe como que vestirá en el tercer aniversario de la fecha de concesión, lo que significa que las unidades serán pagaderas alrededor del 10/08/2028 si se cumplen las condiciones de vesting. El archivo fue firmado por un apoderado en 10/10/2025. No se reportan transacciones derivas ni compras en efectivo.

CFO에게의 내부자 제한 주식 단위 부여

양식 4에는 Christopher H.M. ChanFirst Busey Corp (BUSE)의 최고재무책임자 및 보고자이며 10/08/202521,395개의 제한 주식 단위를 부여받았다고 표시되어 있습니다. 이 보상은 주당 0달러의 취득가로 보고되었으며 부여일의 3주년이 되는 시점에 vesting으로 설명되며, 조건이 충족되면 10/08/2028 경에 주식 단위가 지급될 수 있습니다. 서류는 10/10/2025에 사실대리인에 의해 서명되었습니다. 파생 거래나 현금 매매는 보고되지 않았습니다.

Attribution interne d'unités d'actions restreintes au CFO

Le Formulaire 4 montre Christopher H.M. Chan, directeur financier et personne déclarée chez First Busey Corp (BUSE), qui a reçu une attribution de 21 395 unités d'actions restreintes le 10/08/2025. L'attribution a été reportée comme une acquisition à un prix de 0 $ par action et est décrite comme vestant au troisième anniversaire de la date d'attribution, ce qui signifie que les unités deviendront payables vers le 10/08/2028 si les conditions de vesting sont remplies. Le dépôt a été signé par un mandataire le 10/10/2025. Aucune transaction dérivée ni achat en espèces n'est signalé.

Interne Gewährung von Restricted Stock Units an den CFO

Das Formular 4 zeigt Christopher H.M. Chan, Chief Financial Officer und berichtende Person bei First Busey Corp (BUSE), der eine Zuweisung von 21.395 Restricted Stock Units am 10/08/2025 erhalten hat. Die Zuweisung wurde als Akquisition zu einem Preis von 0 USD pro Aktie gemeldet und wird als Vesting am dritten Jahrestag des Gewährungsdatums beschrieben, was bedeutet, dass die Einheiten voraussichtlich um den 10/08/2028 ausgezahlt werden, sofern die Vesting-Bedingungen erfüllt sind. Die Einreichung wurde am 10/10/2025 von einem Bevollmächtigten unterzeichnet. Es werden keine Derivatransaktionen oder Barankäufe gemeldet.

منح داخلي لوحدات الأسهم المقيدة للرئيس التنفيذي المالي

يعرض النموذج 4 Christopher H.M. Chan، الرئيس التنفيذي المالي والشخص المبلغ لدى First Busey Corp (BUSE)، الذي تلقى منحة قدرها 21,395 وحدة أسهم مقيدة في 10/08/2025. تم الإبلاغ عن الجائزة كاقتناء بسعر 0 دولار للسهم وتوصف بأنها تستحق في الذكرى الثالثة لتاريخ المنح، مما يعني أن الوحدات ستصبح قابلة للدفع نحو 10/08/2028 إذا تحققت شروط الاستحقاق. تم توقيع الملف بواسطة وكيل قانوني في 10/10/2025. لا توجد معاملات مشتقة أو مشتريات نقدية مبلغة.

首席财务官受限股单位的内部授予

表格4显示 Christopher H.M. Chan,为 First Busey Corp (BUSE) 的首席财务官及报告人,在 10/08/2025 收到 21,395 个受限股票单位的授予。该奖励被报道为以每股0美元价格的获取,并描述为在授予日期的第三个周年时 vest,意味着如果 vesting 条件满足,这些单位将于大约 10/08/2028 给付。该备案在 10/10/2025 由一名代理人签署。未报告任何衍生交易或现金购买。

Positive
  • Retention-focused award: 21,395 RSUs vesting on the third anniversary supports executive retention
  • Alignment with shareholders: time-based equity ties CFO incentives to long-term equity performance
Negative
  • Potential dilution: issuance of 21,395 RSUs will increase outstanding equity upon settlement
  • Limited detail on conditions: filing specifies time-based vesting but does not disclose performance or forfeiture details

Insights

Grant aligns executive pay with long-term retention through time-based RSUs.

The award of 21,395 restricted stock units is a time‑based equity grant that vests on the third anniversary of the grant, tying value realization to continued service rather than immediate cash payout. This structure supports retention and aligns the CFO's incentives with shareholder equity performance over a multi-year horizon.

Key dependencies include continued employment and any standard forfeiture conditions; there is no cash exercise, and the filing lists the acquisition at $0 which reflects a compensation grant rather than a market purchase. Monitor equity dilution and total outstanding RSUs in upcoming proxy or 10‑K disclosures within the next 12 months.

Routine disclosure under Section 16 with clear vesting schedule and signatory attestation.

The Form 4 properly reports the transaction date of 10/08/2025 and includes a statement that the RSUs vest on the third anniversary, satisfying Section 16 reporting requirements for officer compensation events. The signature by an attorney‑in‑fact on 10/10/2025 documents timely filing practice.

Risks are administrative: ensure the proxy/compensation discussion in forthcoming filings discloses aggregate awards and potential acceleration clauses if present. Expect related summary compensation details in the next annual proxy statement.

Assegnazione interna di unità azionarie ristrette al CFO

Il modulo 4 mostra Christopher H.M. Chan, Chief Financial Officer e persona reportante presso First Busey Corp (BUSE), che ha ricevuto un'assegnazione di 21.395 unità azionarie ristrette il 10/08/2025. L'assegnazione è stata riportata come un'acquisizione al prezzo per azione di 0 dollari e viene descritta come maturante al terzo anniversario della data di concessione, il che significa che le unità diventeranno pagabili verso 10/08/2028 se venissero soddisfatte le condizioni di vesting. La pratica è stata firmata da un procuratore ad acta il 10/10/2025. Non sono riportate transazioni derivate né acquisti in contanti.

Concesión interna de unidades de acciones restringidas al CFO

El Formulario 4 muestra Christopher H.M. Chan, Chief Financial Officer y persona reportante de First Busey Corp (BUSE), quien recibió una adjudicación de 21,395 unidades de acciones restringidas el 10/08/2025. La adjudicación se informó como una adquisición a un precio de 0 dólares por acción y se describe como que vestirá en el tercer aniversario de la fecha de concesión, lo que significa que las unidades serán pagaderas alrededor del 10/08/2028 si se cumplen las condiciones de vesting. El archivo fue firmado por un apoderado en 10/10/2025. No se reportan transacciones derivas ni compras en efectivo.

CFO에게의 내부자 제한 주식 단위 부여

양식 4에는 Christopher H.M. ChanFirst Busey Corp (BUSE)의 최고재무책임자 및 보고자이며 10/08/202521,395개의 제한 주식 단위를 부여받았다고 표시되어 있습니다. 이 보상은 주당 0달러의 취득가로 보고되었으며 부여일의 3주년이 되는 시점에 vesting으로 설명되며, 조건이 충족되면 10/08/2028 경에 주식 단위가 지급될 수 있습니다. 서류는 10/10/2025에 사실대리인에 의해 서명되었습니다. 파생 거래나 현금 매매는 보고되지 않았습니다.

Attribution interne d'unités d'actions restreintes au CFO

Le Formulaire 4 montre Christopher H.M. Chan, directeur financier et personne déclarée chez First Busey Corp (BUSE), qui a reçu une attribution de 21 395 unités d'actions restreintes le 10/08/2025. L'attribution a été reportée comme une acquisition à un prix de 0 $ par action et est décrite comme vestant au troisième anniversaire de la date d'attribution, ce qui signifie que les unités deviendront payables vers le 10/08/2028 si les conditions de vesting sont remplies. Le dépôt a été signé par un mandataire le 10/10/2025. Aucune transaction dérivée ni achat en espèces n'est signalé.

Interne Gewährung von Restricted Stock Units an den CFO

Das Formular 4 zeigt Christopher H.M. Chan, Chief Financial Officer und berichtende Person bei First Busey Corp (BUSE), der eine Zuweisung von 21.395 Restricted Stock Units am 10/08/2025 erhalten hat. Die Zuweisung wurde als Akquisition zu einem Preis von 0 USD pro Aktie gemeldet und wird als Vesting am dritten Jahrestag des Gewährungsdatums beschrieben, was bedeutet, dass die Einheiten voraussichtlich um den 10/08/2028 ausgezahlt werden, sofern die Vesting-Bedingungen erfüllt sind. Die Einreichung wurde am 10/10/2025 von einem Bevollmächtigten unterzeichnet. Es werden keine Derivatransaktionen oder Barankäufe gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chan Christopher H.M.

(Last) (First) (Middle)
11440 TOMAHAWK CREEK PARKWAY

(Street)
LEAWOOD KS 66211

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIRST BUSEY CORP /NV/ [ BUSE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/08/2025 A 21,395(1) A $0 21,395 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant by the Board of Directors of Restricted Stock Units which vest on the third anniversary of the grant date.
Remarks:
/s/ Carolyn Slattery, attorney-in-fact 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher Chan report on the Form 4 for BUSE?

He reported receipt of 21,395 restricted stock units acquired on 10/08/2025 that vest on the third anniversary of the grant.

When do the RSUs reported for BUSE vest?

The filing states the RSUs vest on the third anniversary of the grant date (around 10/08/2028 if standard calendar years apply).

Was there a purchase price for the reported securities on the Form 4?

No cash purchase was reported; the transaction is listed at a price of $0, indicating a compensation grant.

Does the Form 4 show any option exercises or derivative transactions for BUSE?

No. Table II for derivative securities shows no reported transactions; only the non-derivative RSU grant is listed.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney-in-fact, Carolyn Slattery, on 10/10/2025.
First Busey

NASDAQ:BUSE

BUSE Rankings

BUSE Latest News

BUSE Latest SEC Filings

BUSE Stock Data

2.07B
83.69M
6.02%
62.17%
1.28%
Banks - Regional
State Commercial Banks
Link
United States
LEAWOOD